Longeveron Shares Gain After Lead Product Gets FDA Orphan Drug Tag For Type Of Congenital Heart DefectBenzinga • 12/03/21
Longeveron Announces Clinical Collaboration To Study Cell Therapy Aging Treatment In Japan: Why It MattersBenzinga • 11/30/21
Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty PatientsGlobeNewsWire • 11/30/21
MemeMoney: Longeveron is the short squeeze Reddit Apes can give thanks for this yearMarket Watch • 11/24/21
MemeMoney: Some squeeze-loving retail investors are being cautious about all those shorts on LongeveronMarket Watch • 11/23/21
U.S. Food and Drug Administration Approves Longeveron's Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart ConditionGlobeNewsWire • 11/18/21
Longeveron Inc. (LGVN) CEO Geoff Green on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/12/21